NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO) on behalf of Cano Health stockholders. Our investigation concerns whether Cano Health has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On February 28, 2022, Cano issued a press release “announc[ing] it will delay its fourth quarter and full year 2021 earnings release, conference call and 2022 guidance updates, previously scheduled for Monday, February 28, 2022.”
Cano stated that it “currently anticipates filing a Form 12b-25, Notification of Late Filing, no later than March 2, 2022, which will provide the Company with a 15-day calendar extension to file its Form 10-K” and “expects to report fourth quarter and full year 2021 earnings, as well as increased full year 2022 guidance, on or before March 16, 2022, the expiration date of the extension period.”
On this news, Cano’s stock price fell $0.32 per share, or 6.17%, to close at $4.87 per share on February 28, 2022.
If you purchased or otherwise acquired Cano Health shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
